Madrigal Pharmaceuticals, Inc.
MDGL· Nasdaq
Released Mar 14, 2013, before the open
10-K filed Mar 14, 2013, 73 days after period end · 0001047469-13-002698
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2012 | Q4 2011 | Q4 2010dderived from reported figures |
|---|---|---|---|
| EPS Diluted | -$0.29 | -$0.22 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Madrigal Pharmaceuticals, Inc. · CIK 1157601 · Engraved from SEC EDGAR
ended Dec 31, 2012 · filed Mar 14, 2013 · 73 d after period end